je.st
news
Patient's Death Halts Cancer Drug Trial
2013-11-07 14:51:25| Biotech - Topix.net
A phase I study of an investigational oral inhibitor of apoptosis antagonist, CUDC-427, has been placed on partial clinical hold by the FDA following the death of a patient who had progressed to liver failure approximately 1 month after the discontinuation of CUDC-427 dosing.
Tags: death
trial
drug
cancer
Category:Biotechnology and Pharmaceuticals